I don't expect interim data for a while. The company surely isn't going to release data from each patient. I would assume they'll complete a substantial part if not the whole cohort before any conclusions are drawn and published.
I see no reason to get nervous with no news at the moment. Nothing is ever quick in this sector, if the outcome is good you'll be handsomely rewarded for your patience. If it's no good, than too bad. That's the nature of the beast.
RCE Price at posting:
$1.06 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)